Stuart Allan Division of Neuroscience and Experimental Neurology. Faculty of Biology, Medicine, and Health. University of Manchester, UK, University of Manchester, United Kingdom
2 protocols

Markus Schwaninger Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany
1 protocol

Peter Thornton Innovative Medicines and Early Development, Neuroscience, AstraZeneca, United Kingdom
1 protocol

Josefine Brands Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany
1 protocol

Thomas Walther
  • Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany
  • 1 Author merit
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.